CAS 63968-75-2
:4-chloro-N-(2-methyl-1H-indol-1-yl)-3-sulfamoylbenzamide
Indapamide Related Compound A (4-chloro-N-(2-methyl-1H-indol-1-yl)-3-sulfamoylbenzamide)
CAS:Sulfonamides, nesoiFormula:C16H14ClN3O3SColor and Shape:Yellow Brown PowderMolecular weight:363.04444INDAPAMIDE RELATED COMPOUND A (50 MG) (4-CHLORO-N-(2-METHYL-INDOL-1-YL)-3-SULFAMOYLBEN-ZAMIDE) (AS)
CAS:Formula:C16H14ClN3O3SPurity:98%Color and Shape:SolidMolecular weight:363.8187Indapamide EP Impurity B (Indapamide USP Related Compound A, Dehydro Indapamide)
CAS:Formula:C16H14ClN3O3SColor and Shape:White To Off-White SolidMolecular weight:363.83Indapamide
CAS:Controlled ProductFormula:C16H14ClN3O3SColor and Shape:White To Off-WhiteMolecular weight:363.824-Chloro-N-(2-methyl-1H-indol-1-yl)-3-sulphamoylbenzamide
CAS:Controlled ProductFormula:C16H14ClN3O3SColor and Shape:White To Light BrownMolecular weight:363.82Dehydro Indapamide
CAS:Controlled ProductImpurity Indapamide USP Related Compound A/ Indapamide EP Impurity B
Applications A metabolite of Indapamide (M5). A dehydrogenation pathway by cytochromes P450. Indapamide USP Related Compound A
References Tamura A., et al.: Chem. Pharm. Bull., 38, 225 (1990), Harlow, G.R., et al.: J. Biol. Chem., 272, 5396 (1997), Ozden, T., et al.: Pharm. Pharmacol. Commun., 4, 397 (1998), Gruciani, G., et al.: J. Med. Chem., 48, 6970 (2005), Sun, H., et al.: Drug. Metab. Dispos., 37, 672 (2009),Formula:C16H14ClN3O3SColor and Shape:NeatMolecular weight:363.82Dehydroindapamide
CAS:Dehydroindapamide is the indole form of Indapamide that serves as a quantitative analytical standard for measuring Indapamide turnover by CYP3A4, demonstrating approximately tenfold higher metabolic turnover than Indoline and slightly enhanced CYP3A4 affinity, thereby supporting detailed studies of drug metabolism, enzyme kinetics, and pharmacokinetic profiling.Formula:C16H14ClN3O3SPurity:99.65%Color and Shape:White SolidMolecular weight:363.82Dehydro indapamide
CAS:Dehydro indapamide is a drug that belongs to the class of antihypertensive agents. It is a prodrug that is metabolized in vivo to indapamide and hydrochlorothiazide. Dehydro indapamide has been shown to be efficacious in the treatment of hypertension, and it has a pharmacokinetic profile similar to other diuretics. The clinical data for this drug are limited, but there have been no serious side effects reported with its use.
Formula:C16H14ClN3O3SPurity:Min. 95%Molecular weight:363.82 g/mol











